Skip to content
AXTI

AXT INC

AXT INC Q3 FY2024 earnings call

October 31, 2024 · fiscal period ended 2024-09

EPS · actual vs est

$-0.05 / $-0.06Beat +16.7%

Revenue · actual vs est

$23.6M / $23.5MBeat +0.6%
Ask about this call

Summary

Generated 2024-10-31

Management highlights

Product Segments - Indium phosphide: $6.8 million, driven by data center applications (AI, passive optical networks) and new product development for silicon photonics and EMLs. - Gallium arsenide: $6.6 million, pulled back after strong Q2 growth, with market recovery lumpy but potential from new fiscal stimulus in China. - Germanium substrates: $1.6 million, down due to avoiding low-margin opportunities, with expectations of bottoming in Q4. - Raw material joint venture: $8.6 million, grew on healthy demand. ### Business Initiatives - IPO progress: Tongmei's IPO application remains in-process, with positive momentum from China's stimulus package. - HPT applications: Traction in gallium arsenide HPT applications, leveraging 8-inch development for 6-inch production to improve cost structure.

View in transcript ↓

Segment performance

Revenue for the third quarter of 2024 was $23.6 million. By product category: Indium phosphide was $6.8 million, Gallium arsenide was $6.6 million, Germanium substrates were $1.6 million, and revenue from consolidated raw material joint venture companies was $8.6 million. Regional revenue breakdown: Asia Pacific 77%, Europe 12%, North America 11%. Non-GAAP gross margin was 24.3%, GAAP gross margin was 24.0%. Total non-GAAP operating expense in Q3 was $9.0 million, non-GAAP operating loss was $2.6 million.

View in transcript ↓

Guidance

Q4 Revenue - Expected to be slightly improved, between $23.0 million and $25.0 million, with growth in indium phosphide and raw materials offsetting germanium decline. ### Net Loss - Non-GAAP net loss expected in the range of $0.03 to $0.05 per share. - GAAP net loss expected in the range of $0.05 to $0.07 per share.

View in transcript ↓

Risks

Risks - Financial performance of partially owned supply chain companies. - Increased environmental regulations in China. - COVID or other contagious disease outbreaks. - Germanium raw material pricing negatively affecting gross margins.

View in transcript ↓

Q&A highlights

Q: How big of a surprise was the germanium business dynamics?

A: The germanium raw material price more than doubled, leading to declining germanium revenue in Q4, but the business is expected to return as the market settles.

Q: What are the drivers for indium phosphide growth?

A: Demand in data centers (AI, passive optical networks), new product development for silicon photonics and EMLs, and growth in orders from silicon photonics customers.

Q: What's the visibility on HPT applications in gallium arsenide?

A: Market size is $80 million to $100 million, with 10% current market share and opportunity to increase share by leveraging development learnings for 6-inch production.

Q: Impact of China stimulus on AXT?

A: Stimulus could positively impact consumer, industrial activities, cell phones, and aid in the STAR listing of Tongmei.

Q: Progress on China's STAR listing?

A: Tongmei's application remains in-process, with positive momentum from China's stimulus package and ongoing diligence by regulators.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$-0.05$-0.06+16.7%$-0.12
Revenue$23.6M$23.5M+0.6%$17.4M

Transcript

October 31, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.